Darwin AG (Munich:7V0.MU)
| Market Cap | 78.00M-1.5% |
| Revenue (ttm) | 52.35M |
| Net Income | -3.43M |
| EPS | 0.05 |
| Shares Out | 12.00M |
| PE Ratio | 130.00 |
| Forward PE | 1300.00 |
| Dividend | €0.56(8.62%) |
| Ex-Dividend Date | Jun 29, 2026 |
| Volume | 0 |
| Open | 6.50 |
| Previous Close | 6.50 |
| Day's Range | 6.50 - 6.50 |
| 52-Week Range | 5.70 - 11.80 |
| Beta | 0.26 |
| Analysts | none |
| Price Target | 19.38(+198.08%) |
| Earnings Date | n/a |
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
About 7V0.MU
Novogenia AG manufactures and sells personalized health products in global markets. The company offers products, such as personalized supplements and cosmetics; and services, including genetic testing, advanced therapies like personalized infusion therapies and reproductive genetics, and contract manufacturing. The company was formerly known as Darwin AG and changed its name to Novogenia AG in June 2026. The company was incorporated in 2021 and is based in Munich, Germany.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$7V0.MU stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in 7V0.MU holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by 7V0.MU's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
7V0.MU Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New 7V0.MU patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to 7V0.MU from public contracts
Source: USAspending.gov
7V0.MU Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from 7V0.MU’s recent data — informational, not investment advice